Home LiteratureArticle Details
PMID: 2987659 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site.

Molecular pharmacology ·Vol. 27 ·No. 6 ·1985-06-00 ·Pages 612-23

Rhodes DG, Sarmiento JG, Herbette LG

Abstract

Using the model of 1,4-dihydropyridine calcium channel-blocking drug binding to receptors in the cardiac sarcolemmal membrane, diffusion-limited rates of association were calculated for two distinct approaches. In the "aqueous approach," the drug reaches the receptor by diffusion through the bulk solvent, whereas in the "membrane approach," the drug partitions into the membrane bilayer and then diffuses laterally to a specific receptor site. Calculated rates for the membrane approach were approximately 3 orders of magnitude greater than those for the aqueous approach. The membrane approach diffusion-limited rate depends weakly on the sizes of the binding site, the drug molecule, and the vesicle, but depends strongly on ligand asymmetry. Although the measured binding rates for several 1,4-dihydropyridines were all slower than the calculated diffusion-limited rates for either model, other experimental data (such as very high partition coefficients and specific positions of these drugs in the membrane bilayer) suggest that the membrane approach is the most likely. These results have important implications for specifying critical characteristics of active 1,4-dihydropyridines.

MeSH Terms
Animals Calcium Channel Blockers/metabolism Calcium Channels Diffusion Dihydropyridines Kinetics Ligands Lipid Bilayers/metabolism Mathematics Models, Biological Myocardium/metabolism Pyridines/metabolism Receptors, Nicotinic/metabolism Sarcolemma/metabolism
Chemicals
Calcium Channel Blockers Calcium Channels Dihydropyridines Ligands Lipid Bilayers Pyridines Receptors, Nicotinic 1,4-dihydropyridine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rhodes D G
Sarmiento J G
Herbette L G
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
1985-06-00
Pages
612-23
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NHLBI NIH HHS · HL-21812 · United States
NHLBI NIH HHS · HL-27630 · United States
NHLBI NIH HHS · HL-32588 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com